$SNX

HUME RICHARD T sold $1.4M of SNX

HUME RICHARD T sold 5,000 shares of TD SYNNEX CORP (SNX) at an average of $280.38 ($272.75–$285.26, $1.40M total) across 11 trades on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HUME RICHARD T
Published Jun 3, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:46 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNX
Bearish
medium confidence
Mentioned
$SNX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNXBearishLow
01

Why it matters

The disclosed sale may prompt short‑term traders to watch SNX for possible price dip.

02

Market read

Primary insider sale news with modest materiality; limited trading relevance.

03

What to watch

The director retains a sizable stake, suggesting continued confidence.

Relevance 5/10Novelty 6/10Timing: post‑market today

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the sale.

Company-level read

Ticker impact

$SNXBearishMedium confidence
Context

Director Richard Hume sold $1.4M of SNX shares via a 10b5‑1 plan, reducing his stake to 23,537 shares.

Expected impact

potential slight downward pressure as market absorbs the director's sale

Evidence & confidence

A $1.4M open‑market sale by a director signals possible concerns, but the amount is modest relative to the company's market cap.

Market effects

Minimal impact on the broader technology distribution sector.

Limited to U.S. investors tracking SNX.

None

Counterpoint

The sale could be routine under a pre‑arranged plan and not indicate negative fundamentals.

Key entities

  • TD SYNNEX Corp

    Issuer of the shares sold.

  • Richard Hume

    Director of TD SYNNEX who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNXMed

TD SYNNEX stock: BlueStar deal follows a cash-flow reversal

TD SYNNEX agreed to buy BlueStar, expanding its tech distribution. The deal lacks a disclosed price and awaits approvals. TD SYNNEX's latest quarter showed $416.2M net income but a $916.7M operating cash outflow, raising cash-flow concerns. Shares fell 2.46% on Oct 7. BlueStar's addition could broaden offerings, but financial details are unclear.

$TDMed

TD SYNNEX Adding Specialty Technology Distributor BlueStar

TD SYNNEX agreed to acquire BlueStar, a specialty tech distributor, to expand its offerings. BlueStar focuses on tech like RFID and robotics. TD SYNNEX reported Q3 revenue of $21.6B, up 37.7% Y/Y, and forecasts Q4 revenue of $21.8B-$22.6B. The deal is subject to approvals.

$TDMed

TD SYNNEX to Acquire Specialty Technology Distributor BlueStar

TD SYNNEX agreed to acquire BlueStar, a specialty tech distributor. The deal expands TD SYNNEX's capabilities in AIDC, operational tech, and mobility. Financial terms were not disclosed. The transaction is subject to regulatory approvals. Both companies will operate independently until closing. BlueStar specializes in technologies like RFID and point-of-sale systems. TD SYNNEX plans to combine BlueStar's expertise with its global platform.

$SNXHigh

TD SYNNEX to acquire specialty distributor BlueStar

TD SYNNEX (NYSE:SNX) agreed to acquire BlueStar, a specialty tech distributor. The deal is pending regulatory approval. BlueStar specializes in AIDC and related technologies. Financial terms were not disclosed. Both companies will operate independently until the transaction closes. SNX is a global distributor supporting 150,000+ customers across 100+ countries.